Reeves to cut Cash ISA allowance to £12,000

Rachel Reeves is reportedly preparing to slash the Cash ISA allowance to £12,000 in tomorrow’s Budget in a move that is supposed to spur investment in the UK stock market.

HMRC data shows that around 15 million adult ISAs were subscribed to in 2023/24, and the large majority were Cash ISAs – just under 10 million.

Around £726bn is held in ISA accounts across the UK, with the majority already in Stocks & Shares ISAs. Only around £100bn is held by people with £20k who only save in Cash ISAs and don’t invest.

The big question here is whether savers will actually choose to use the remainder of their allowance by investing in Stocks and Shares ISAs.

Some will, but it’s likely most will keep it in cash and take the tax hit on the interest. Like most of Reeves’ economic policies, the changes to the Cash ISA allowance are already dead on arrival.

The problem here is a lack of confidence to invest in stocks and generally poor financial literacy in the UK. Slashing the Cash ISA allowance will not solve this.

“We need an investment culture in the UK, and some of the money that has been saved in cash ISAs would work harder for people if it was invested instead, but there’s no evidence that cutting the cash ISA allowance would encourage them to make the change,” said Sarah Coles, head of personal finance, Hargreaves Lansdown.

“There will be people for whom cash ISAs are the most sensible home for their money, especially if they’re saving for the short term, have significant sums of cash and are a higher earner.  When HL surveyed clients as to what they would do in the event of a cut, they were equally likely to say a cut in the allowance would mean saving elsewhere as they were to say they would invest instead.

“There will be those who should be investing instead, but the gamechanger here will be changes in the pipeline to allow businesses to provide more targeted support and give people the help they need to take advantage of the enormous growth potential of investment. It’s the carrot that’s going to be effective here: not the stick.”

AIM movers: Parkmead cash and CelLBxHealth fundraising

1

Gas producer Parkmead Group (LON: PMG) generated revenues of £4m from its remaining gas assets in the year to June 2025. There was a £11.8m accounting gain on the disposal of Parkmead (E&P). Cash was £13.2m at year-end and there are up to £120m of contingent payments. This will provide finance for moves into renewable energy and for taking advantage of gas opportunities. The share price increased 14.5% to 15p.    

Womenswear retailer Sosandar (LON: SOS) is gaining momentum this year. Interim revenues were 15% higher at £18.7m, while sales were 28% ahead on the company’s website. Sales to Marks & Spencer were hit by that retailer’s cyber incident, but they have started again. The six stores are loss-making, but the first two are moving towards breakeven. The interim loss increased from £700,000 to £1.1m, but a full year pre-tax profit is anticipated. Net cash was £7.7m at the end of September. The share price recovered 4.56% to 6.875p.

Defence services provider RC Fornax (LON: RCFX) has secured a framework agreement in the space sector. Initial revenues are £370,000 over six months and there could be follow-on revenues. It will retain ownership of IP. The share price rose 6.84% to 6.25p.

Engineering services provider Renew (LON: RNWH) managed to negotiate weaker demand for rail services and still improve operating profit, although higher interest costs meant underlying pre-tax profit dipped from £69.9m to £68.1m. Electricity and renewables services acquisitions added to the figures. Electricity transmission and water services provide significant potential growth. Net cash was £6.2m at the end of September, but that was before the acquisition of Emerald Power. The bank facility has increased from £120m to £140m for a four-year term. This provides funding for further acquisitions. The share price is 4% higher at 949.5p.

FALLERS

CelLBxHealth (LON: CLBX) has raised £6.8m at 1p/share and could raise up to £1m more from a retail offer. A capital reorganisation will reduce the nominal value of the shares so that they can be issued at this price. There will be £1.9m spent on R&D, £1m for sales and market and £1.2m for reorganisation and IT systems. The cancer diagnostics company will progress partnerships and reduce annual operating costs by more than £5.9m. Ther will also be development of additional assays for the Parsortix platform. The share price slid 31.3% to 1.1p.

Security technology supplier Thruvision (LON:THRU) grew interim revenues 36% to £2.6m, even though retail revenues were lower. Cash was £2.1m at the end of September 2025. The second half will be tougher than expected and Allenby has reduced its full year revenues forecast from £8m to £5m, while the loss is raised from £2.21m to £3.55m. There will still be cash by the end of March 2026. The share price fell 27.3% to 0.6p.

Engineer Pipehawk (LON: PIP) shares initially rose on the release of full year results but are now down 9.68% to 1.4p. There was a drop in revenues, but continuing revenues grew 27% to £3.7m. The loss was reduced from £1.64m to £310,000. Management is seeking business outside the UK, where utilities and government spending has been delayed.

Consumer goods supplier Supreme (LON: SUP) reported interims boosted by acquisitions and vape sales were higher than expected. This offset lower electricals sales. Revenues were 17% higher at £132.6m. Pre-tax profit declined from £12.9m to £12.2m. The dividend was reduced to 1.6p/share in line with earnngs. Net debt was £4.1m at the end of September 2025. The banning of disposable vapes led to a move to reusable pods and there was an initial boost to sales in the period. This may not continue in the second half, but there will be greater contributions from acquisitions. The share price declined 5.36% to 159p.

FTSE 100 gains as investors gear up for Budget

The FTSE 100 showed the signs of caution you’d expect ahead of the Rachel Reeves widely feared Budget, with upbeat news from the tech sector across the pond helping offset any nervousness on the UK front.

London’s leading index had flipped between positive and negative territory during the morning session, though a strong overnight session for US stocks helped it 0.4% higher at the time of writing.

“UK stocks are shaking off a dicey end to last week as increased hopes of a pre-Christmas interest rate cut from the Federal Reserve give stocks on both sides of the Atlantic a boost,” says Dan Coatsworth, head of markets at AJ Bell.

“Tech stocks powered the recovery on Wall Street yesterday and fostered hope of a Santa Rally as we approach the beginning of December. Google-owner Alphabet is closing in on a $4 trillion valuation as enthusiasm builds around its Gemini 3 AI model and its custom chips.”

It’s interesting to see Nvidia shares down and Google higher in the US premarket after reports that Meta will use Google chips in their AI push. Nvidia was down 3% while Google rallied 4%.

In the UK, Kingfisher charged to the top of the FTSE 100 leaderboard after releasing an encouraging Q3 update. Strong sales in the UK and Ireland drove a more-than-welcome uptick in profit guidance and sent shares 5% higher.

“DIY conglomerate Kingfisher, the name behind B&Q and Screwfix gave an encouraging update, raised its full-year guidance despite softening market conditions in the UK where it remains mindful of inflation and tomorrow’s Budget,” said Derren Nathan, head of equity research, Hargreaves Lansdown.

“Strategic initiatives and a focus on efficiency saw the group raise its underlying pre-tax profit guidance from around £540 million to a range of £540-£570 million. Kingfisher is gaining share in a challenging market and despite the recent recovery in the share price still offers a dividend yield of over 4% as well as the potential for some modest capital appreciation.”

Miners were also among the best performers on Tuesday after a call between Donald Trump and the Chinese Premier raised hopes that the worst of the trade tensions are now behind us. Antofagasta and Anglo American both rose by more than 2%.

Insurer Beazley was the top faller, shedding 10%, on news that written insurance premiums rose only 1% as rates on renewal business fell 4%. The drop briefly took Beazley shares back to the lowest levels since 2024.

Next shares rose 1% after announcing the sale of land it no longer needed for £54m.


Kingfisher impresses with improved profit outlook

Kingfisher shares jumped on Tuesday after the DIY group raised its profit guidance, driven by strong performance in the UK and Ireland.

Kingfisher reported group like-for-like sales growth of 0.9% in the third quarter, rising to 1.6% year-to-date on an underlying basis, driven by continued volume and transaction growth. Total group sales reached £3.25bn in the quarter and £10.06bn for the nine months.

The UK and Ireland delivered the standout performance, with LFL sales up 3.0% in Q3 as the group continued to gain market share.

Strong momentum in trade and e-commerce channels bolstered results, with trade sales climbing 12.1% to reach 31.3% penetration, whilst e-commerce sales grew 10.2% to 20.7% penetration.

“Kingfisher’s quarter suggests the strategy is finally gaining some traction. B&Q and Screwfix are clearly winning the battle for market share in the UK, with the shift towards trade and online channels paying dividends,” explained Chris Beauchamp, Chief Market Analyst UK at IG.

Kingfisher shares were 5% higher at the time of writing.

Performance was more subdued in continental Europe. French LFL sales declined 2.5% in constant currency terms, with year-to-date sales down 2.3%. Poland saw LFL sales fall 1.3% in the quarter and 1.8% year-to-date, with both markets reflecting softer consumer demand.

Despite softness in Europe, the retailer upgraded its full-year adjusted profit before tax guidance to approximately £540m-£570m, up from the previous range of £480m-£540m.

The company has completed £175m of its current £300m share buyback programme, which remains on track for completion by March 2026.

“Kingfisher’s latest trading update presents a cautiously optimistic tone, with the company raising profit guidance, supported by solid UK and Ireland performance and ongoing operational improvements,” said Adam Vettese, market analyst for eToro.

“The continuation of a £300 million share buyback programme highlights management’s confidence in future cash generation, while digital investments are driving higher online sales penetration and maintaining market share across core brands.”

easyjet shares slip on disappointing outlook

easyJet shares slipped on Tuesday after reporting a 9% increase in pre-tax profit to £665 million for the year ending 30 September 2025, representing its third consecutive year of earnings growth.

Guidance, however, wasn’t as encouraging amid rising costs amid strategic improvements to easyJet’s network.

The budget airline’s headline earnings before interest and tax jumped 18% to £703 million, driven by strength in both its airline and holidays divisions. 

EasyJet shares were down 2% at the time of writing.

Investors might have hoped for a bit of a pop higher given the stock’s poor performance over the summer months, but it appears profits just weren’t strong enough to spark a major reaction. 

“The outlook for the new year brought some mixed news,” said Aarin Chiekrie, equity analyst, Hargreaves Lansdown.

“Winter losses are set to get worse, coming in around £30 million behind market expectations, as ongoing investment in its new strategic bases in Milan and Rome continues. Looking past this, management’s hoping to grow capacity by around 7% this year, or nearly double the sector average, and first-half bookings are already tracking ahead of the prior year. With a net cash pile of over £0.6 billion, there’s also plenty of cushion if the market experiences some turbulence.”

The airline business contributed £415 million in pre-tax profit, whilst easyJet holidays achieved £250 million. This target has been achieved ahead of schedule.

Following the uptick in activity, the company has upgraded its holiday division target to £450 million pre-tax profit by 2030. The airline expanded capacity by 9% during the year, with seats up 4%. 

“A 9% rise in pre-tax profit would be respectable for any carrier, but it will be EasyJet’s holiday division that turns investors’ heads,” explained Mark Crouch, market analyst for eToro.

“Slowly becoming the group’s profit engine, the package division delivered £250mn of PBT on 20% customer growth and 32% profit growth, so buoyant, in fact, that management has already upgraded medium-term targets it thought would take longer to hit.”

However, revenue per available seat kilometre fell 3% as the company invested in longer leisure and city routes whilst opening new bases at Milan Linate, Rome Fiumicino and London Southend. 

Cost efficiency improved, with headline cost per available seat kilometre down 3%, helped by a 7% reduction in fuel costs.

In terms of the dividend, easyJet has outlines a payout worth 20% of headline profit after tax, payable in early 2026.​​​​​​​​​​​​​​​​

Non-invasive disease detection through a scan of the eye with Occuity

The UK Investor Magazine was thrilled to welcome Dan Daly, Founder & CEO of Occuity, and CCO Mark Jenkins to delve into Occuity’s eye scanning disease detection technology.

Find out more about Occuity on Republic here.

Occuity is developing handheld, non-contact devices that use the eye as a window to the body’s health.

The company’s patented optical technology already addresses glaucoma and myopia, while future products will target disease screening and, ultimately, a non-invasive glucose meter for diabetes monitoring.

Occuity enables screening of glaucoma, myopia and diabetes through optical MedTech backed by 15 patents and £4 million in grant funding. Its first product is selling globally through 19 distributors. The company has established a proven platform with a strategic pipeline of products in development.

The company has been busy forging commercial partnerships and is well placed to push forward with its growth strategy on the completion of their current fundraising round.

Cerillion growth set to accelerate this year

2

Growth slowed at AIM-quoted telecoms enterprise software provider Cerillion (LON:CER) last year, but that was due to the timing of contract wins. This year growth will accelerate because of contracts already won and there could be further wins in the coming months.

In the year to September 2025, revenues were 4% ahead at £45.4m – they were lower at the interim stage. Underlying pre-tax profit was 10% higher at £21.8m. The total dividend is 15.4p/share, up 17%. Net cash is £34.4m.

New orders were 25% higher at £47.6m. There was a contract with an existing customer worth £25.3m in total that was won at the end of the period. Including recurring maintenance and other revenues, there is around £25m of revenues already booked for this financial year.

The potential sales pipeline is at a new record level of £275m even after the recent contract wins. There is continued investment in technology, including AI.

Mergers in Cerillion’s market sector are likely to reduce competition at tenders and they are also providing opportunities to take on experienced staff from the merged entities.

Panmure Liberum forecasts 2025-26 revenues of £54m, while margins are likely to decline from their current high levels due to investment in additional sales staff. Pre-tax profit is forecast at £22.7m, rising to £24.9m next year. Cerillion tends to beat forecasts and a large contact win early enough in the year would boost the current forecast.  

The share price is 55p higher at 1410p, but it is 19% lower this year. The prospective multiple is 24 and cash will continue to increase.

FTSE 100 lifted by miners ahead of this week’s Budget

The FTSE 100 was higher on Monday as mining companies helped lift the index after BHP called time on its pursuit of Anglo American.

Traders will also find confidence in a strong rebound in US stocks on Friday, which will ease concerns about AI valuations and the outlook for interest rates.

London’s leading index was 10 points higher at the time of writing as traders eyed this week’s Budget and potential implications for UK markets.

“Equities up, gold down, bitcoin stable – this is a remarkably different picture than last week’s troubling scenes that dogged financial markets,” says Russ Mould, investment director at AJ Bell.

“It suggests investors have had time to collect their thoughts over the weekend, and to start the new week in a calmer mood. It also helps that Ukraine peace talks have dominated the news agenda, giving hope to investors and individuals around the world.”

The FTSE 100 had been higher earlier in the session, but the rally faded as the session progressed. Investors will look to US markets for the next catalyst as cash trading gets underway this afternoon.

The mining sector was the key driving force behind the gains after BHP pulled out of its pursuit of Anglo American, saying ‘it is no longer considering a combination of the two companies.’

BHP’s decision boosted the miners as investors positioned for possible M&A elsewhere in the sector.

“Miners were in vogue amid ongoing M&A activity in the sector. News that BHP has walked away from a second attempt to buy Anglo American has left investors hungry for action elsewhere,” Russ Mould said.

“Glencore was among the top risers on the FTSE as it is seen as a potential merger candidate for one of the big players, or as a buyer itself.”

Glencore rose 1.9% but it was the precious metals miners that had their noses out in front. Endeavour Mining was the top riser with a 3.7% gain, while Fresnillo rose 3.1%.

BAE Systems and Babcock were the biggest decliners, with talks to end the war in Ukraine underway. BAE Systems lost 2% and Babcock fell 1.9%.

There was a tinge of weakness in UK-centric sectors such as retailers and some financials ahead of Wednesday’s Budget.

AIM movers: Microlise hit by lower volumes and Kropz production increase

1

Kropz (LON: KRPZ) produced 87,496 tonnes of phosphate concentrate n the third quarter and sales were 28% higher at 72,408 tonnes. September was a record production month, and the mine is still in its trial production phase. The share price rebounded 27.5% to 0.65p, but it has still halved since the beginning of the year.

Trellus Health (LON: TRLS), which has developed digital technology to manage chronic conditions, has secured a $600,000 loan from 25% shareholder Icahn School of Medicine at Mount Sinai. There is no interest charge for nine months and then the annual rate is 8%. The loan is convertible into shares, but the stake cannot go above 29.9%. This will provide enough cash until late January when more cash will be required. The share price increased 23.8% to 0.65p.

Polarean Imaging (LON: POLX) has entered an exclusive distribution agreement for the Xenon MRI platform with DK Healthcare in South Korea. Polarean Imaging plans to leave AIM later this year. The share price recovered 11.8% to 0.095p.

MTI Wireless Edge (LON: MWE) reported record third quarter revenues and nine month revenues were 12% ahead at $37.8m. Operating profit was 21% higher at $4.2m. Net cash improved to $6.4m. Antenna revenues were one-fifth higher due to increasing defence demand. That offset weaker 5G demand in India. The water irrigation technology and electronics division also grew in the third quarters. The fourth quarter has stated strongly. The share price rose 9.41% to 46.5p.

GlobalData (LON: DATA) is launching a £10m share buyback and there will be further news on the timing of the move to the Main Market in January. The share price improved 9.72% to 109.5p.

FALLERS

Telematics supplier Microlise Group (LON: SAAS) says lower OEM volumes due to tariffs and the weak economy. There have also been delays in projects. There are plans to cut annualised costs by £4m. That is too late for 2025 when forecast revenues have been cut from £91.3m to £84m, while earnings have been slashed from 5.5p/share to 3.1p/share. The 2026 earnings forecast has been cut to 4.9p/share. Customer churn remains low. The share price slumped 30.1% to 97.5p.

Immupharma (LON: IMM) continues to talk with potential partners for the P140 autoimmune platform and a deal will not be secured until 2026. There is enough cash until the fourth quarter of 2026, so there is no need for a fundraising. Deals with commercial partners should provide additional finance. The share price declined 27.4% to 7.09p.

Oil and gas producer Prospex Energy (LON: PXEN) has generated revenues of £4.2m so far this year, despite the downtime at Viura and El Romeral and lower gas prices. Viura is back in production in the fourth quarter. This will enable much larger revenues in the period and generate cash for investment. The share price slipped 12.8% to 3.4p.

M&C Saatchi (LON: SAA) was hit by the US government shutdown and this has led to a downgrade of expectations for 2025. The media business has done better than expected. Group revenues have been reduced by 1% to £210m, while pre-tax profit is cut by 19% to £22.4m. There is an even greater reduction from £34m to £24.7m for 2026. Net cash of £18.5m is forecast for the end of 2025. A £5m share buyback has been launched. The share price fell 8.73% to 115p.

S4 Capital shares tumble as revenue outlook lowered

S4 Capital shares fell on Monday after the marketing group downgraded its full-year guidance following weaker-than-expected October performance.

The digital advertising group now expects 2025 like-for-like net revenue to fall just under 10%.

Shares were down 9% at the time of writing.

The revenue shortfall will hit profitability hard. Operational EBITDA is now targeted at approximately £75 million, significantly below the £81.6 million market consensus. Management blamed lower project-based revenue, continued client caution, and slower-than-anticipated conversion of new business wins.

S4’s struggles mirror those of WPP, which is also facing difficulties in the current environment.

The company has already implemented cost-cutting measures this year. However, liquidity remains stronger than forecast, with year-end net debt still expected between £100 million and £140 million.